Abstract:
The present invention is directed to a novel method for preparing a synthetic intermediate for treprostinil via a stereoselective alkyne addition reaction. Also described are methods of preparing treprostinil comprising the alkyne addition reaction described herein as well as novel intermediates useful for synthesis prostacyclin derivatives, such as treprostinil.
Abstract:
This present invention relates to an improved process to prepare prostacyclin derivatives. One embodiment provides for an improved process to convert benzindene triol to treprostinil via salts of treprostinil and to purify treprostinil.
Abstract:
This present invention relates to an improved process to prepare prostacyclin derivatives. One embodiment provides for an improved process to convert benzindene triol to treprostinil via salts of treprostinil and to purify treprostinil.
Abstract:
Locking mechanisms and methods of fixation, such as the fixation of a fixation device like a bone screw and of a rod to the spine. The locking mechanism includes a body, a rod seat and a set screw. The rod seat is configured to separate into two pieces when the rod exerts force on the top portion of the washer and the set screw limits movement of the washer toward the bottom of the locking mechanism.
Abstract:
There is provided a stable monohydrate form of treprostinil and pharmaceutical formulation comprising the same, method of making and using the same.
Abstract:
A rod, such as that used for spinal stabilization, made of both metal material and elastomeric material. The rod may have a metal infrastructure, which may be non-cylindrical, to provide a desired stiffness for bending in at least one direction and may also have metal exterior surfaces for engaging metal components of spinal fixation locking mechanisms. In addition, the elastomeric material may only partially circumferentially encapsulate the metal material so that the metal material forms part of the surface of the rod.
Abstract:
Methods of treating chronic arthritis and osteoporosis which utilize both known and novel compounds which would fall under the general formula:(HO)p--A--[--OS(O).sub.2 NR.sup.1 R.sup.2 ].sub.zwherein A encompasses a wide range of values including but not limited to aryl, loweralkyl, cycloalkyl, and carbohydrates including sucrose and fructose; p is equal to the number of unreacted hydroxy groups contained on the molecule and may be zero; z is the number of --OS(O).sub.2 NR.sup.1 R.sup.2 groups and is always at least one; R.sup.1 and R.sup.2 are selected from hydrogen, loweralkyl, carboxy and the like; a novel process for preparing the compounds is provided wherein an appropriate sulfamic acid aryl ester is reacted with a hydroxy substituted A radical which may or may not contain thereon protected carboxyl, amino or hydroxy substituents, in an aprotic solvent containing a tertiary amine base. Pharmaceutical compositions for the treatment of chronic arthritis and osteoporosis are also provided.
Abstract:
Novel compounds of the formula: ##STR1## are disclosed wherein Ar and Ar.sup.1 are phenyl, sustituted phenyl or pyridinyl, "alk" is a C.sub.1 -C.sub.12 straight or branched hydrocarbon chain, and R is H, loweralkylcarbonyl, arylcarbonyl, or aminocarbonyl where the amino is unsubstituted or substituted by one or two groups selected from loweralkyl or aryl. The compounds of this invention are useful in the treatment of allergic disorders.
Abstract:
Herein disclosed is a method of treating convulsions with a pharmaceutical composition containing a compound of the formula:(HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.zwhere A is an aryl, arylalkyl, or aryloxyalkyl group and is substituted on 1 or more carbon atoms with a sulfamate group (--OSO.sub.2 NR.sup.1 R.sup.2) wherein R.sup.1 and R.sup.2, same or different, are hydrogen or loweralkyl wherein p is 0 or 1 and is the number of untreated hydroxyl groups and z is 1 or 2 and is the number of --OS(O.sub.2)NR.sup.1 R.sup.2 groups. Aryl is selected from phenyl, substituted phenyl, pyridinyl, naphthyl, quinolinyl, and the like. Phenyl substituents are selected from hydrogen, halo, hydroxy, phenyl, phenoxy, benzoyl, loweralkyl, loweralkoxy, carboxy, amino, loweralkylamino, diloweralkylamino, acetamido, cyano, nitro, loweralkoxycarboyl, aminosulfonyl, imidazolyl, triazolyl, and the like. Novel compounds not previously disclosed are also described.
Abstract translation:本文公开了一种用药物组合物治疗惊厥的方法,所述药物组合物含有下式化合物:(HO)pA- [OSO 2 NR 1 R 2] z,其中A是芳基,芳基烷基或芳氧基烷基,并被一个或多个碳原子取代, 氨基磺酸酯基(-OSO2NR1R2)其中R1和R2相同或不同,为氢或低级烷基,其中p为0或1,为未经处理的羟基数,z为1或2,为-OS(O 2)NR 1 R 2的数目 团体 芳基选自苯基,取代的苯基,吡啶基,萘基,喹啉基等。 苯基取代基选自氢,卤素,羟基,苯基,苯氧基,苯甲酰基,低级烷基,低级烷氧基,羧基,氨基,低级烷基氨基,二低级烷基氨基,乙酰氨基,氰基,硝基,低级烷氧基羰基,氨基磺酰基,咪唑基,三唑基等。 还描述了以前未公开的新型化合物。
Abstract:
A dynamic rod assembly, such as that used for spinal stabilization, made of a number of interlocking segments whereby a limited amount of relative motion is permitted between each pair of adjacent segments. The dynamic rod assembly may also incorporate a separate central element that extends at least partially through a central channel within the interlocking segments to prevent the interlocking segments from disengaging while adding to the desired bending properties of the dynamic rod assembly.